Top 50 Biotech VC Funds & Investors in Middle East (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Trendlines Group
VC Fund
|
21 | Israel, Singapore, United Kingdom | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $650k–$62M |
|
Israel Innovation Authority
VC Fund
|
18 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $100k–$6M |
|
OurCrowd
VC Fund
|
17 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $500k–$60M |
|
Pontifax
VC Fund
|
16 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
OrbiMed
VC Fund
|
11 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $8M–$160M |
|
FutuRx
VC Fund
|
10 | Israel | Seed, Venture - Series Unknown | Biotechnology, Biopharma, Therapeutics | |
|
TRANGELS
VC Fund
|
10 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $55k–$1.4M |
|
Docor International Management
VC Fund
|
9 | Israel, United States | Series C, Series B | Health Care, Biotechnology, Medical Device | $2M–$22M |
|
SOSV
VC Fund
|
8 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
aMoon Fund
VC Fund
|
8 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
HBL Hadasit Bio Holdings
VC Fund
|
8 | Israel | Venture - Series Unknown, Seed, Series A | Biotechnology, Medical, Health Care | $2.4M–$47M |
|
Welltech Ventures
VC Fund
|
7 | Israel, United States, Poland | Seed, Series A, Venture - Series Unknown | Health Care, Artificial Intelligence, mHealth | $718k–$20M |
|
ZORA Ventures
VC Fund
|
7 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Biotechnology, Health Care, Software | $1M–$8.6M |
|
RMGP Biopharma Investment Fund
VC Fund
|
7 | Israel | Seed, Series B, Venture - Series Unknown | Biotechnology, Biopharma, Therapeutics | |
|
Clal Biotechnology Industries
VC Fund
|
7 | Israel, United States | Series A, Venture - Series Unknown, Series B | Health Care, Biotechnology, Medical Device | $4M–$55M |
|
Arkin Capital
VC Fund
|
6 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$95M |
|
Egypt Ventures
VC Fund
|
6 | Egypt, United States, The Netherlands | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, FinTech | $28k–$120M |
|
S2G Investments
VC Fund
|
6 | United States, Canada, United Kingdom | Series A, Series B, Venture - Series Unknown | Food and Beverage, Agriculture, Biotechnology | $3.9M–$100M |
|
Milk & Honey Ventures
VC Fund
|
5 | Israel | Pre-Seed, Seed, Series A | Food and Beverage, Biotechnology, Nutrition | $1M–$5.2M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
5 | Israel, United States | Series A, Series B, Series C | Health Care, Biotechnology, Medical Device | $4.4M–$55M |
|
Siddhi Capital
VC Fund
|
5 | United States, Israel, Canada | Seed, Series A, Pre-Seed | Food and Beverage, Biotechnology, AgTech | $1M–$21M |
|
iVentures Asia
VC Fund
|
5 | Israel, United States, Hong Kong | Seed, Convertible Note, Series A | Software, Biotechnology, Mobile | $800k–$5.5M |
|
Sapir Venture Partners
VC Fund
|
5 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Analytics | $305k–$40M |
|
Consensus Business Group
VC Fund
|
5 | Israel, United States, United Kingdom | Series B, Seed | Health Care, Medical Device, Medical | $1.3M–$80M |
|
Agriline
VC Fund
|
5 | Israel | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Biotechnology | $1.3M–$17M |
|
iAngels
VC Fund
|
5 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Financial Services | $120k–$22M |
|
Istcapital
VC Fund
|
5 | Turkey, United States, United Kingdom | Seed, Series A | Artificial Intelligence, Biotechnology, SaaS | $230k–$10M |
|
Diffusion Capital Partners
VC Fund
|
5 | Turkey, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $59k–$3M |
|
Kinisis Ventures
VC Fund
|
5 | Cyprus, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Manufacturing, Energy, 3D Technology | $218k–$2.6M |
|
SOSV SF & NY (Fka IndieBio)
VC Fund
|
5 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Biotechnology, Health Care, Medical | $50k–$5M |
|
Entrée Capital
VC Fund
|
5 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.3M–$54M |
|
GlenRock Israel
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Cyber Security | $100k–$30M |
|
Millenium Food-Tech
VC Fund
|
4 | Israel | Seed, Series A, Series B | Food and Beverage, Manufacturing, Retail | $2.5M–$105M |
|
Tnuva
VC Fund
|
4 | Israel | Seed, Series A, Series B | Biotechnology, Food and Beverage, Food Processing | $1.2M–$6M |
|
fresh.fund
VC Fund
|
4 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Health Care | $300k–$21M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
New York Ventures
VC Fund
|
4 | United States, Canada, Israel | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1M–$53M |
|
Grove Ventures
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.3M–$74M |
|
Cancer Focus Fund
VC Fund
|
4 | Israel, United States, Germany | Venture - Series Unknown, Series A, Seed | Biotechnology, Medical, Health Care | $4.5M–$47M |
|
South Israel Bridging Fund
VC Fund
|
4 | Israel, Cyprus, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Software, Energy | $750k–$34M |
|
Takeda Ventures
VC Fund
|
4 | United States, United Kingdom, Israel | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $12M–$130M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
4 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
Hatcher+
VC Fund
|
4 | United States, Italy, Australia | Pre-Seed, Seed, Convertible Note | Software, Information Technology, Health Care | $50k–$1.5M |
|
Sente Ventures
VC Fund
|
3 | United States, Turkey, Israel | Pre-Seed, Convertible Note, Seed | Artificial Intelligence, Machine Learning, Software | $50k–$1.5M |
|
Good Seed Ventures
VC Fund
|
3 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $55k–$50M |
|
Tempo Beverages Cyprus Ltd.
VC Fund
|
3 | Israel | Venture - Series Unknown, Series A | Biotechnology, AgTech, Nutrition | $1.5M–$9M |
|
DSM Venturing
VC Fund
|
3 | United States, Canada, Israel | Series A, Series B | Biotechnology, Health Care, Manufacturing | $3.5M–$32M |
|
Pitango VC
VC Fund
|
3 | United States, Israel, United Kingdom | Series B, Series A, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
Acasia Group
VC Fund
|
3 | Egypt, United States, Nigeria | Seed, Angel, Venture - Series Unknown | Mobile, E-Commerce, Financial Services | $50k–$2.6M |
|
Neo Ventures
VC Fund
|
3 | Israel, United Kingdom, Estonia | Seed, Series A | Software, Artificial Intelligence, Aerospace | |
| Access all 50 VC funds in Middle East Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag Innovation Fund. The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-tech products. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 219
- Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $10M in 2023
Portfolio highlights
- DeepBrief — DeepBrief is an artificial intelligence platform designed for automated performance analysis in clinical training. The platform serves medical faculties, academic institutions, and simulation centers. The software helps instructors analyze medical simulations and real clinical events. It extracts data from recorded training sessions to build detailed timelines of events. It tracks mechanical actions such as pulse checks and physical examinations.
- PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 409
- Round size: Seed $500k–$8M; Series A $2.5M–$22M; Series B $5.5M–$60M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- BloomX — Helping nature do its magic with the power of technology
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — The determination of people living with inclusion body myositis inspires our work and strengthens our resolve to advance precision therapies with the potential to change what's possible.
- Crystalys Therapeutics — Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 790
- Round size: Series A $8M–$116M; Series B $18M–$148M; Series C $18M–$160M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- CoGenesys — CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Therapeutics
- Stage:Seed, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- A2i Therapeutics — A2i Therapeutics develops novel therapeutic modulators of the protein that helps to control the immune response and neurological disorders.
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 60
- Round size: Seed $67k–$1.4M; Angel $100k–$500k; Pre-Seed $55k–$500k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Datasance — Securely deploy, manage, and scale containerized workloads across thousands of heterogeneous far-edge and IoT environments.
- Trawell Data — Trawell Data is a mobile data services company that provides travelers to use mobile data on their mobile phones without changing phones or sim cards. It enables the phone to digitally connect and use the local operator. Trawell Data was established in 2015 and is headquartered in Syosset, New York.
- Visionteractive — Visionteractive develops social media based, fun and interactive physical and digital products, bridging the gap between online and actual world. The company aims to bring a brand together with the target audience by developing various creative products, while enhancing the memorability owing to the interactive experience with the users.Visionteractive was founded on 2013 and is based in Turkey.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series C, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 19
- Round size: Series B $2M–$3.5M; Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
- SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
- Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 80
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $340M in 2022
Portfolio highlights
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology. It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU"). In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU. HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 11
- Round size: Venture - Series Unknown $2.4M–$47M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, mHealth
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel, United States, Poland
Investor stats
- Total investments: 23
- Round size: Seed $718k–$19M; Series A $6M–$20M; Venture - Series Unknown $3M–$5.3M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
- Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
- Marquee — Marquee turns football data into decision-ready insights in seconds, unifying external and internal data and filtering it through your club's sporting DNA.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $1M–$8.6M; Series A $4M–$8.1M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $740k in 2020
Portfolio highlights
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
- Earth Force Technologies — Earth Force is a Vegetation Management System platform.
RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Therapeutics
- Stage:Seed, Series B, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Circuit-Bio — Circuit-Bio is a synthetic biology company developing a unique platform of logical gene circuits for cancer immunotherapy. The platform used by the company focuses on creating gene circuits that can precisely and locally manufacture a combination of several immune-stimulating proteins (immunomodulators) that are only expressed in specific tumorcells. The circuit turns cancer cells into "Trojan horses" that are used as anti-tumor resources and incite a potent, long-lasting immune response.
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 20
- Round size: Series A $4M–$55M; Series B $15M–$40M; Venture - Series Unknown $4M–$18M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 32
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fresh fund, raised $100M in 2026
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
- Werewolf Therapeutics — Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Egypt, United States, The Netherlands
Investor stats
- Total investments: 38
- Round size: Seed $250k–$3M; Pre-Seed $28k–$2M; Venture - Series Unknown $3.2M–$120M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
- D OCC Hub — Smart Incident Management Solutions
- InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 232
- Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$100M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $1B in 2026
Portfolio highlights
- Formic Technologies — At Formic, we want to increase the collective output of humanity by making automation deployments trivial and easy. Every factory should have access to unlimited 'labor' through robotics and automation rentals. We are building technology, financing, operations and services to make this vision possible.Formic is a fast-growingventure-backed startup focused on unlocking robotic automation in labor-starved industries such as food and beverage, advanced manufacturing, consumer packaged goods and other industrial settings. We combine financial innovation with a firm understanding of what robotics are capable of, to enable manufacturing customers to scale up their manufacturing capacity quickly and with minimal risk.
- 3C Datalec — 3C Datalec refers to a newly formed entity created through a merger between 3C and Datalec Precision Installations
- Wilde Brands — Thin and crispy, flavorful, and 7x the protein of a potato chip. Wilde Chips are grain & gluten free, Paleo certified, Keto friendly, non-GMO & allergen-free.
Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Nutrition
- Stage:Pre-Seed, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 6
- Round size: Seed $3.5M–$5.2M; Pre-Seed $1M–$2.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 16
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, AgTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 60
- Round size: Seed $2M–$6.3M; Pre-Seed $1M–$3.6M; Series A $5M–$21M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely actively investing — fresh fund, raised $475k in 2026
Portfolio highlights
- Nopalera — Vegan, cruelty free, and Latina owned. Handmade cactus products that celebrate culture and resilience.
- Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
- ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
iVentures Asia is a Hong Kong-based venture capital fund that offers end-to-end support to their portfolio companies. The company was founded by Benjamin Weiss in November 2013.
Show more...Investment focus
- Industry: Software, Biotechnology, Mobile
- Stage:Seed, Convertible Note, Series A
- Geography: Israel, United States, Hong Kong
Investor stats
- Total investments: 25
- Round size: Seed $800k–$2.4M; Series A $4M–$5.5M; Convertible Note $820k–$3M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Vision Travel AI — Vision Travel AI is a groundbreaking platform based in China, dedicated to transforming the cultural tourism industry through the fusion of VR/AR technologies and artificial intelligence. By recreating historical scenes and providing immersive cultural experiences, Vision Travel AI allows tourists to explore and engage with history like neverbefore.Vision Travel AI utilizes virtual reality (VR) technology to create completely virtual environments. These environments transport tourists back in time, allowing them to experience historical scenes as if they were actually there. When tourists visit historical sites, they can use devices like smartphones or AR glasses to see reconstructions of ruins and historical landmarks. One of the standout features of Vision Travel AI is its interactive guide system, featuring the Guide BOT Digital Human. Upon entering a site, visitors can activate this digital guide to begin an "Ask and Answer Tour." The Guide BOT functions like a real tour guide, offering detailed introductions to artifacts, buildings, and historical contexts. Tourists can interrupt the Guide BOT at any time to ask questions, receiving instant, in-depth answers that expand their knowledge and understanding of the site. Vision Travel AI's innovative approach to cultural tourism transforms the way people connect with history. Vision Travel AI has established partnerships with over 7 historical and cultural sites globally, enhancing visitor experiences through cutting-edge technology. A significant collaboration with Sichuan Province's Dujiangyan Irrigation System, a UNESCO World Heritage site, has brought ancient Chinese engineering marvels to life for visitors through immersive VR/AR experiences.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $1.3M–$10M; Pre-Seed $305k–$800k; Series A $10M–$40M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $1.3M–$4.5M; Series B $11M–$80M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
iAngels is a women-led venture capital firm and one of Israel's most active and recognized investors. Combining a deep, proprietary due-diligence process alongside best-in-class reporting, iAngels provides a window into Israel's extremely rich startup world and has a proven ability to generate and deliver superior VC returns. iAngels believes in going beyond and backs those who do, partnering with some of the highest-caliber entrepreneurs in the nation.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 139
- Round size: Seed $900k–$10M; Pre-Seed $120k–$400k; Series A $4.2M–$22M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $56M in 2021
Portfolio highlights
- Nas Daily —
- Recapp — The feed every fan deserves. Download Recapp now.
- Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
ISTcapital is a family office-backed venture capital firm partnering with exceptional founders to build early-stage, global technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, SaaS
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $230k–$3M; Series A $500k–$10M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Cellestetix — Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness.
- Spline — Spline is a free 3D design tool in the browser. Your team and its agents model, animate and ship interactive 3D together, in real time.
- PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $350k–$3M; Pre-Seed $59k–$1.4M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- BigOmics — Get robust and reproducible results in a few clicks with Omics Playground: your user-friendly Omics Data Analysis Software.
- Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
- GoWit Technology — Unlock your retail media potential with GoWit's omnichannel Retail Media Advertising platform. Expand your audience reach, optimize bidding, and leverage first-party data for maximum conversions and privacy protection.
Kinisis Ventures is a venture capital firm backing bold founders building the future. Discover our portfolio, meet our team, and explore how we support startups from seed to scale.
Show more...Investment focus
- Industry: Manufacturing, Energy, 3D Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Cyprus, United States, United Kingdom
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$2.6M; Venture - Series Unknown $218k–$1.4M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Phase3D — Phase3D develops in-situ monitoring technology for additive manufacturing, providing real-time, layer-by-layer inspection of 3D printing processes. Their flagship product, Fringe, uses structured light to detect and quantify anomalies during printing, offering data in microns for quality assessment. Fringe is compatible with various industrial 3Dprinters and can be retrofitted to existing equipment. The system helps users identify issues early and take action to maintain part integrity.
- Autonomics — Autonomics is developing a city cleaning solution to help municipalities make the urban environment a clean, healthy, and cozy place to live with robotics and AI.
- ProMed BioSciences — Promed is an EU-based, highly innovative biotech company, developing collagen-based biomaterials
IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 676
- Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
- Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves. We back founders with a partnership built on trust, fairness and real operating experience. We stand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 316
- Round size: Seed $1.3M–$16M; Series A $5M–$30M; Series B $17M–$54M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $175M in 2025
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
- Ultra Security — Ultra Security protects AI agents by monitoring actions, enforcing security policies, preventing threats, and safeguarding sensitive data.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Health Care, Cyber Security
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 38
- Round size: Seed $1M–$9M; Series A $1.5M–$12M; Series B $100k–$30M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
- Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.
Show more...Investment focus
- Industry: Food and Beverage, Manufacturing, Retail
- Stage:Seed, Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 20
- Round size: Seed $2.5M–$6M; Series A $3M–$15M; Series B $17M–$105M
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- TripleW Group NV — Making Waste History. TripleW upcycles food waste into high-value bioplastic
- ansā — Ansā is a coffee roasting solution designed specifically for the workplace. It offers a system that enables organizations to roast coffee on-site. The solution focuses on providing fresh coffee tailored to workplace preferences. The industries served include food service and hospitality.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
On the Tnuva website you will find information about the Company, its subsidiaries, press releases, the Program for Better Nutrition, contacting customer service and more.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Seed, Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
- Ever After Foods — We produce slaughter-free meats that prevent animal cruelty, and support health, security and sustainability for our planet and its people.
- ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 44
- Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely actively investing — fresh fund, raised $7.9M in 2025
Portfolio highlights
- Kimba — Kimba is an adaptive scent sleep system that uses sleep and biometric data to deliver personalized, natural-origin scents at specific moments throughout the night, designed to actively improve sleep rather than simply track it.
- CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
- Shifters AI — Shifters AI develops and enables teams of robots to move autonomously through complex terrain.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 158
- Round size: Seed $1M–$6.2M; Series A $3M–$20M; Series B $4M–$53M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Fathom Therapeutics — The Molecular Frontier
- CREW Carbon — CREW provides wastewater treatment facilities with a process intensification solution that improves performance, lowers costs, and permanently removes greenhouse gasses.
- Fesarius Therapeutics — Intelligently Patterned Native-State Hydrogel Wound Dressing for Dermal Tissue Regeneration...
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 76
- Round size: Seed $3.3M–$20M; Series A $8M–$50M; Series B $22M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $1.5M in 2024
Portfolio highlights
- Particula — Particula brings new life into Rubik's cube, dice, and chess using AI, connectivity, and interactivity. Enter a smart games world with modern versions of classics!
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 10
- Round size: Series A $5.4M–$28M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 60% lead, 40% follow
- Last fund: Likely actively investing — fresh fund, raised $23M in 2025
Portfolio highlights
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
South Israel Bridging Fund is a venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Software, Energy
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Israel, Cyprus, United States
Investor stats
- Total investments: 23
- Round size: Series A $1.5M–$34M; Series B $7M–$25M; Venture - Series Unknown $750k–$2M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $200M in 2020
Portfolio highlights
- Gadfin — Gadfin design and develops long-range Urgent-delivery systems of the future, which is no less than a game-changer for the Medical and Time-critical deliveries market. Its system brings together traditional flight knowledge, unmanned and autonomy technology, thus redefining delivery capabilities in terms of flight radius, safety, reliability, andautomation, that is going to disrupt the world.
- Stargo — Stargo turns messy enterprise data into trusted operational transactions across freight, logistics, supply chain, insurance, fintech, government, and automotive.
- Electriq Global — Electriq is a hydrogen carrier that acts like coffee powder for a coffee machine - simplifying storage, transport, and use of hydrogen in off-grid applications and long-term storage.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance to entrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $12M–$58M; Series B $21M–$130M; Series C $30M–$115M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 80
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
- Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: United States, Italy, Australia
Investor stats
- Total investments: 195
- Round size: Seed $50k–$1.5M; Pre-Seed $50k–$1.2M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Inaam — inaam is an Australian impact investing app. Pick five themes, customise them and read every company you hold by name. Flat $10 a month, $100 minimum to invest.
- M-Based — M-Based develops next-generation biomaterials using mushroom, redefining sustainability in design and materials.
- Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Sente is a Chicago-based startup investment and innovation platform. Sente searches the world for the most high-potential startups and helps them scale through unprecedented guidance, support, and connections.
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Pre-Seed, Convertible Note, Seed
- Geography: United States, Turkey, Israel
Investor stats
- Total investments: 39
- Round size: Pre-Seed $50k–$1.5M; Convertible Note $50k–$50k
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Kfobix Inc. — Revolutionizing Grid Maintenance with AI and Robotics
- M-Based — M-Based develops next-generation biomaterials using mushroom, redefining sustainability in design and materials.
- Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 39
- Round size: Seed $55k–$7M; Series A $7.5M–$50M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Tempo Beverages Cyprus Ltd. is a producer and distributor of alcoholic and non-alcoholic beverages and the leading wine grower and wine producer in Israel. Tempo Beverages Cyprus Ltd is a subsidiary company of Tempo Israel, which is partially owned by Heineken NV Group.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Nutrition
- Stage:Venture - Series Unknown, Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $1.5M–$9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
- Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
- ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 92
- Round size: Series A $3.5M–$32M; Series B $4.1M–$30M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- Athian — Funding livestock sustainability via a connected carbon marketplace.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Phynova Group — Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcareproducts derived from active compounds found in plants. Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.
Pitango is Israel's premier venture capital firm, managing over $3B in committed capital across early-stage, growth & healthtech funds.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 333
- Round size: Series A $4M–$40M; Series B $8.1M–$55M; Series C $7.8M–$100M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
- Catch — Catch is the trusted AI Executive Assistant that actually gets work done.
- QuantHealth — Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more...Investment focus
- Industry: Mobile, E-Commerce, Financial Services
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: Egypt, United States, Nigeria
Investor stats
- Total investments: 44
- Round size: Seed $50k–$2.6M; Angel $200k–$300k
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $1M in 2022
Portfolio highlights
- Bosta — Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. Bosta was founded in 2017 and is headquartered in Cairo, Al Qahirah, Egypt.
- EFG EV Fintech — EFG EV Fintech is investing in startups and bolstering the Fintech ecosystem in the process. EFG EV Fintech combines the financial know-how of EFG Hermes and entrepreneurial expertise of Egypt Ventures to launch the a Fintech-focused startup accelerator.They invest in rising Fintech startups with the potential to grow domestically and expandbeyond the Egyptian market. EFG EV Fintech also provides innovators with the fully integrated services they need to thrive – from funding to mentorship, to training, and office space.
- Tagaddod — Tagaddod is a renewable Energy and Waste Management Egyptian company, started in February 2013 and operating in Cairo –Egypt. Currently focusing on clean fuels, Tagaddod is working on Biodiesel production from Vegetable Oils. Biodiesel is a fuel alternative that is produced from waste vegetable oils and used in conventional diesel engines, whichcan directly substitute for or extend supplies of traditional petroleum diesel.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United Kingdom, Estonia
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!